Publication / Source: Bioanalysis 4(19)
Authors: Hill MH
“While technical innovations have made the possibility of more rapid sample flow a reality, they have also made it possible to develop more robust methods in a timely manner.”
Increased productivity in business has always been important. In the current pharma industry environment, this has never been more imperative. The reasons for this have been well documented over the past few years, and bioanalysis is not immune from this. Indeed, the provision of analytical results in a timely manner can be pivotal to maintaining schedules as well as containing costs. Productivity may appear to be easily defined, that is, more results for lower costs (in the same timeframe).